"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about LARIAM
• Ask Community about LARIAM
• LARIAM Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

LARIAM Safety Questions, LARIAM Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LARIAM. Our extensive database of LARIAM adverse events and LARIAM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LARIAM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

LARIAM Safety Reports

Total LARIAM reports: 133.
LARIAM FDA safety alerts: 2002 2003 .
Reported deaths: 15    Reported hospitalizations: 61.
Take LARIAM Side Effects Survey or Share Your LARIAM Story. LARIAM Usage.

Showing 1-75 of 133 Next >

Physician from UNITED KINGDOM reported LARIAM problem on May 26, 2006. Male patient, 25 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, amnesia, anxiety, asthenia, bedridden, confusional state, depression, diarrhoea, disease recurrence. LARIAM dosage: unknown. During the same period patient was treated with ARTESUNATE, CHLOROQUINE PHOSPHATE, DOXYCYCLINE. Patient recovered.

LARIAM problem was reported by a Physician from UNITED KINGDOM on June 19, 2006. Male patient, 62 years of age, weighting 194.0 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, panic attack, psychiatric symptom, suicidal ideation. LARIAM dosage: unknown. During the same period patient was treated with TEOPTIC. Patient recovered.

Consumer or non-health professional from SWEDEN reported LARIAM problem on July 06, 2006. Female patient, 24 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, anxiety, dyspnoea, sensation of foreign body. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Female patient, weighting 110.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, affect lability, anger, anxiety, depression, dizziness, headache, insomnia, nausea. LARIAM dosage: 250 MG 1 TABLET WEEKLY. Patient recovered.

Physician from GERMANY reported LARIAM problem on Aug 15, 2006. Male patient, 39 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: parkinson's disease. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 25, 2006. Female patient, 43 years of age, was diagnosed with prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anaemia, anxiety, confusional state, insomnia, liver disorder, psychotic disorder. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from SWEDEN reported LARIAM problem on Aug 30, 2006. Female patient, child 11 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: iron deficiency, leukopenia. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from NETHERLANDS on Aug 29, 2006. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: thrombosis. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported LARIAM problem on Aug 30, 2006. Female patient, 39 years of age, weighting 229.3 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: ecchymosis, headache, rash, renal failure acute, tendon disorder, urinary tract infection, vaginal infection, vertigo. LARIAM dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, FLAGYL, PARACETAMOL, POLYGYNAX, SOLUBACTER. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Physician from FRANCE on Mar 31, 2006. Male patient, 29 years of age, weighting 163.1 lb, was diagnosed with prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, disturbance in attention, fatigue, vertigo, visual disturbance, vomiting. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LARIAM problem on Sept 20, 2006. Male patient, weighting 160.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, incontinence, tongue biting. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Physician from GERMANY on May 06, 2006. Female patient, 44 years of age, weighting 149.9 lb, was diagnosed with malaria prophylaxis, dental care and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: asthenia, coordination abnormal, dizziness, hot flush, hypertension, nausea, tachycardia, vomiting. LARIAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LARIAM problem on Oct 06, 2006. Male patient, 26 years of age, weighting 187.4 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: inflammation, oral administration complication, pharyngeal ulceration, pharyngolaryngeal pain, tongue ulceration. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2006. Female patient, 39 years of age, weighting 229.3 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, ecchymosis, headache, prurigo, rash erythematous, rash papular, renal failure acute, urinary tract infection. LARIAM dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, FLAGYL, ACETAMINOPHEN, POLYGYNAX, SOLUBACTER. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported LARIAM problem on Aug 15, 2006. Male patient, 39 years of age, weighting 149.9 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: parkinsonism. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Physician from NETHERLANDS on Oct 18, 2006. Female patient, 59 years of age, weighting 196.2 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis. LARIAM dosage: unknown. During the same period patient was treated with COVERSYL PLUS, METOPROLOL TARTRATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Physician from RUSSIAN FEDERATION reported LARIAM problem on Oct 19, 2006. Female patient, 37 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. LARIAM dosage: ONCE ONE TABLET OF 250 MG.. Patient recovered.

LARIAM problem was reported by a Pharmacist from GERMANY on July 31, 2006. Male patient, weighting 13.23 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: convulsion, haematocrit decreased, haemoglobin decreased, respiratory disorder, salivary hypersecretion, vomiting. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported LARIAM problem on May 06, 2006. Female patient, 43 years of age, weighting 149.9 lb, was diagnosed with malaria prophylaxis, dental care and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: asthenia, coordination abnormal, dizziness, hot flush, hypertension, nausea, tachycardia, vomiting. LARIAM dosage: unknown. During the same period patient was treated with FEMOSTON, JODETTEN. Patient recovered.

LARIAM problem was reported by a Physician from NETHERLANDS on Oct 18, 2006. Male patient, 59 years of age, weighting 196.2 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis, malignant hypertension. LARIAM dosage: unknown. During the same period patient was treated with COVERSYL PLUS, SELOKEEN, SIMVASTATIN, COSOPT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LARIAM problem on Nov 22, 2006. Male patient, weighting 180.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, insomnia, panic attack. LARIAM dosage: 250 MG ONCE WEEKLY ORALLY. Patient recovered.

LARIAM problem was reported by a Physician from ITALY on Feb 03, 1999. Female patient, 46 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alcohol use, anorexia, dehydration, depression, diarrhoea, gastroenteritis, gravitational oedema. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from GERMANY reported LARIAM problem on July 31, 2006. Male patient, weighting 13.23 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: convulsion, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, platelet count increased, respiratory disorder, salivary hypersecretion, vomiting. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2006. Male patient, 36 years of age, weighting 154.3 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: fatigue, mood swings, restlessness, tinnitus. LARIAM dosage: THREE PILLS OF 250 MG ONE A WEEK. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LARIAM problem on Dec 07, 2006. Female patient, 27 years of age, weighting 140.0 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abortion induced, aplasia, foetal malformation. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 1998. Male patient, 37 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aortic rupture, completed suicide, depression, facial bones fracture, fall, femur fracture, polytraumatism, skull fracture. LARIAM dosage: unknown. Patient died on 03/04/1998.

Consumer or non-health professional from GERMANY reported LARIAM problem on Feb 01, 1995. Male patient, 23 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, hallucination. LARIAM dosage: unknown. During the same period patient was treated with ALCOHOL. Patient died on 12/25/1994.

LARIAM problem was reported by a Physician from GERMANY on May 06, 2006. Female patient, 43 years of age, weighting 149.9 lb, was diagnosed with malaria prophylaxis, dental care and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: asthenia, coordination abnormal, dizziness, hot flush, hypertension, nausea, tachycardia, vomiting. LARIAM dosage: unknown. During the same period patient was treated with FEMOSTON, JODETTEN. Patient recovered.

Health Professional from SWEDEN reported LARIAM problem on June 21, 2007. Female patient, 20 years of age, was diagnosed with infection parasitic and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: diplopia, headache, neuropathy. LARIAM dosage: unknown. During the same period patient was treated with NORFLOXACIN, MALARONE. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Pharmacist from UNITED KINGDOM on June 27, 2007. Female patient, 36 years of age, weighting 176.4 lb, was diagnosed with malaria prophylaxis, hypertension and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, torsade de pointes. LARIAM dosage: unknown. During the same period patient was treated with WARFARIN, RAMIPRIL, HEPATYRIX, REVAXIS, MENINGOCOCCAL VACCINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LARIAM problem on June 27, 2007. Female patient, 51 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, paraneoplastic syndrome. LARIAM dosage: unknown. During the same period patient was treated with RILUTEK, VITAMIN E, ASCORBIC ACID, VITAMINS NOS, COENZYME Q, ALPHA LIPOIC ACID. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Health Professional from CANADA on July 10, 2007. Female patient, 28 years of age, weighting 125.0 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: asthenia, convulsion, headache, hypoaesthesia, muscle spasms, muscle twitching, nervous system disorder, paraesthesia. LARIAM dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LARIAM problem on July 05, 2007. Male patient, 41 years of age, weighting 175.0 lb, was diagnosed with prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, depression, fatigue, ill-defined disorder, mental disorder, pyrexia, sleep disorder, tremor. LARIAM dosage: unknown. During the same period patient was treated with ATIVAN, LEXAPRO, WELLBUTRIN, ALLEGRA. Patient recovered.

LARIAM problem was reported by a Physician from UNITED KINGDOM on July 05, 2007. Female patient, 52 years of age, weighting 132.3 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: anxiety, chest pain, fatigue, head discomfort, nausea, panic attack, visual disturbance. LARIAM dosage: unknown. During the same period patient was treated with PIZOTIFEN. Patient was hospitalized. Patient recovered.

Physician from NETHERLANDS reported LARIAM problem on July 04, 2007. Female patient, child 4 years of age, weighting 28.66 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Health Professional from NETHERLANDS on July 17, 2007. Female patient, 19 years of age, weighting 165.3 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: bone pain, diarrhoea, disturbance in attention, nightmare, psychotic disorder. LARIAM dosage: unknown. During the same period patient was treated with HEPATITIS A VACCINE, MICROGYNON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LARIAM problem on July 23, 2007. Male patient, 25 years of age, weighting 275.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: epilepsy, infection, partial seizures, swollen tongue, tongue disorder. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from NETHERLANDS on July 17, 2007. Female patient, 29 years of age, weighting 143.3 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, depression. LARIAM dosage: unknown. Patient died on 02/01/1994.

Physician from UNITED STATES reported LARIAM problem on July 17, 2007. Female patient, 33 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: aggression, cognitive disorder, convulsion, flight of ideas, hallucination, insomnia, memory impairment, nightmare, psychotic disorder. LARIAM dosage: unknown. During the same period patient was treated with TYLENOL, IBUPROFEN, BIRTH CONTROL. Patient was hospitalized and became disabled. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on July 30, 2007. Male patient, 32 years of age, weighting 243.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: affect lability, amnesia, anger, anxiety, confusional state, crying, depression, disturbance in attention, dizziness. LARIAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LARIAM problem on July 30, 2007. Female patient, 20 years of age, weighting 160.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: depression, disturbance in attention, dizziness, fatigue, hallucination, auditory, hallucination, olfactory, mania, mood altered, nausea. LARIAM dosage: unknown. Patient recovered.

LARIAM problem was reported by a Physician from FRANCE on July 25, 2007. Female patient, 26 years of age, weighting 123.5 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: amnesia, anxiety, asthenia, cognitive disorder, disturbance in attention, dyspnoea, hallucination, hearing impaired, muscle spasms. LARIAM dosage: unknown. During the same period patient was treated with ETHINYL ESTRADIOL AND LEVONORGESTREL. Patient recovered.

Health Professional from FRANCE reported LARIAM problem on July 24, 2007. Male patient, 62 years of age, was diagnosed with malaria and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Pharmacist from NETHERLANDS on July 31, 2007. Male patient, 59 years of age, weighting 165.3 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, bradycardia, coma, hyperhidrosis, orthostatic hypotension, syncope, tremor. LARIAM dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported LARIAM problem on July 31, 2007. Male patient, 30 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, gastrointestinal disorder, headache, hyperhidrosis, nausea, panic attack, paraesthesia, sensation of foreign body. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Pharmacist from UNITED KINGDOM on Aug 09, 2007. Male patient, 65 years of age, weighting 187.4 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. LARIAM dosage: unknown. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported LARIAM problem on July 31, 2007. Male patient, 59 years of age, was diagnosed with hypertension and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, bradycardia, coma, loss of consciousness, syncope vasovagal. LARIAM dosage: 250 MG (250 MG 1 IN 1 WK). During the same period patient was treated with DOXAZOSIN, FORTZAAR. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2007. Female patient, weighting 115.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anxiety, bruxism, chills, depression, diarrhoea, disturbance in attention, dizziness, fatigue. LARIAM dosage: 250 MG 1 X WEEK. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LARIAM problem on Aug 30, 2007. Male patient, 29 years of age, weighting 270.0 lb, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: accident. LARIAM dosage: unknown. Patient was hospitalized. Patient recovered.

LARIAM problem was reported by a Physician from UNITED KINGDOM on Aug 28, 2007. Male patient, 65 years of age, weighting 187.4 lb, was diagnosed with malaria prophylaxis, dyspepsia and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. LARIAM dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Physician from FRANCE reported LARIAM problem on Aug 29, 2007. Female patient, 60 years of age, weighting 154.3 lb, was diagnosed with malaria prophylaxis, hepatitis b immunisation and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, c-reactive protein increased, cytolytic hepatitis, myalgia, pyrexia, vomiting. LARIAM dosage: unknown. During the same period patient was treated with ENGERIX. Patient recovered.

LARIAM problem was reported by a Health Professional from UNITED KINGDOM on Aug 31, 2007. Female patient, 75 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: polymyalgia rheumatica, red blood cell sedimentation rate increased. LARIAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LARIAM problem on Aug 30, 2007. Male patient, 35 years of age, weighting 242.1 lb, was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, amnesia, anxiety disorder, blood pressure increased, chest pain, deafness, depression, diarrhoea. LARIAM dosage: unknown. During the same period patient was treated with BACTRIM, IMODIUM, COMPAZINE, ANTIBIOTICS NOS, ANTIVERT, PREDNISONE, VALIUM, PHENERGAN. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2007. Male patient, 35 years of age, weighting 242.1 lb, was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, amnesia, anxiety disorder, blood pressure increased, chest pain, deafness, depression, diarrhoea. LARIAM dosage: unknown. During the same period patient was treated with BACTRIM, IMODIUM, COMPAZINE, ANTIBIOTICS NOS, ANTIVERT, PREDNISONE, VALIUM, PHENERGAN. Patient recovered.

Health Professional from UNITED STATES reported LARIAM problem on Sept 04, 2007. Male patient, 41 years of age, weighting 175.0 lb, was diagnosed with prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, depression, fatigue, ill-defined disorder, mental disorder, pyrexia, sleep disorder, tremor. LARIAM dosage: unknown. During the same period patient was treated with ATIVAN, LEXAPRO, WELLBUTRIN, ALLEGRA. Patient recovered.

LARIAM problem was reported by a Pharmacist from NETHERLANDS on Sept 04, 2007. Male patient, 59 years of age, weighting 165.3 lb, was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, bradycardia, hyperhidrosis, orthostatic hypotension, syncope, tremor. LARIAM dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Pharmacist from AUSTRALIA reported LARIAM problem on Sept 05, 2007. Female patient, 24 years of age, was diagnosed with prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hepatic failure, hepatitis fulminant, jaundice, vomiting. LARIAM dosage: unknown. During the same period patient was treated with LEVLEN ED, TETANUS VACCINE, TYPHOID VACCINE, RABIES VACCINE. Patient recovered.

LARIAM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Male patient, 35 years of age, weighting 242.1 lb, was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, amnesia, anxiety disorder, blood pressure increased, brain stem syndrome, chest pain, deafness, depression. LARIAM dosage: unknown. During the same period patient was treated with BACTRIM, IMODIUM, COMPAZINE, ANTIBIOTICS NOS, ANTIVERT, PREDNISONE, VALIUM, PHENERGAN. Patient recovered.

Showing 1-75 of 133 Next >

Ask Our Patient Community about LARIAM
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine) Rebetol (ribavirin) Reclast (zoledronic acid) Refludan (lepirudin recombinant) Relenza (zanamivir) Relpax (eletriptan) Remeron (mirtazapine) Renagel (sevelamer) Rescula (unoprostone isopropyl) Restoril (temazepam) Revatio (sildenafil) Revlimid (lenalidomide) Reyataz (atazanavir sulfate) Ribasphere (ribavarin ribasphere) Ribavarin ribasphere Rifapentine Rifaximin Risedronate Risperdal (risperidone) Risperidone Ritalin (methylphenidate) Ritonavir Rituxan Rituximab Rivastigmine tartrate Rizatriptan Rocephin (ceftriaxone) Rofecoxib Rosuvastatin